TIAN AN MEDICARE LIMITED (00383.HK): Expected H1 Profit Attributable to Shareholders to Range from HK$30 Million to HK$60 Million

NewTimeSpace News: On 7 August 2026, TIAN AN MEDICARE LIMITED (00383.HK) issued a positive profit forecast. Based on preliminary review of the relevant unaudited consolidated management accounts, the Group anticipates profit attributable to shareholders of HK$30 million to HK$60 million for the first half of the year, versus HK$12 million registered in the same period of the prior year.

The announcement stated that the profit growth is mainly driven by higher operating income from the medical segment, reduced non-cash fair value losses on investment properties and increased fair value gains on trading investments. Such positive factors are partially offset by a decline in net foreign exchange gains.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.